Rep. Josh Riley

Maddy summaryThe Kidd's Stuttering Act requires Medicaid and CHIP to screen children aged 2-6 for stuttering and speech fluency during routine well-child visits starting January 1, 2027. It also mandates that Medicaid and CHIP cover specified speech therapy services for childhood stuttering (defined as "specified speech therapy services") with coverage rules no more restrictive than those for other speech disorders like language delays. The bill ensures these services include telehealth options and applies to all states administering Medicaid or CHIP. This directly affects children with stuttering who qualify for Medicaid or CHIP, aiming to improve early detection and access to treatment.

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Maddy summaryThis bill allows workers aged 50 or older to directly roll over employer retirement contributions (from 401(k) plans) into an individual retirement annuity without triggering immediate taxes or penalties. It requires retirement plan administrators to provide clear, plain-language written explanations about rollover rules, including a 30-day review period, tax implications (like the 10% early withdrawal penalty), and what types of distributions cannot be rolled over (such as required minimum distributions). The rules apply to taxable years starting after December 31, 2025, and aim to simplify the process for older workers changing jobs or managing retirement funds. It directly affects workers aged 50+ and retirement plan administrators who must comply with the new disclosure standards.

Maddy summaryThis bill would expand Medicare Part B coverage to include medical nutrition therapy for beneficiaries with a wider range of chronic conditions beyond current limits (diabetes and kidney disease). It specifically adds conditions like obesity, hypertension, eating disorders, cancer, gastrointestinal diseases, and HIV to the list of covered illnesses, allowing coverage for prevention, management, or treatment. The bill also allows more healthcare providers - including dietitians, nurse practitioners, and clinical psychologists - to deliver these services. This change would directly affect millions of Medicare beneficiaries managing these conditions who previously lacked coverage for medically necessary nutrition therapy.

Maddy summaryThis bill expands Medicare's drug price negotiation program to cover 50 drugs (up from 20) and requires health insurers to apply negotiated prices to cost-sharing for beneficiaries. It establishes annual out-of-pocket cost-sharing limits for prescription drugs under group health plans and insurance coverage, with specific limits of $2,000 for self-only coverage in 2027 that will increase annually. The bill also sets specific cost-sharing limits for insulin products, requiring coverage with no deductible and cost-sharing of no more than $35 per 30-day supply or 25% of the negotiated price. These provisions affect Medicare beneficiaries, people with group health plans, and health insurers across the country. The bill applies to plan years beginning on or after January 1, 2027.

Maddy summaryHR 6181, the John Lewis Every Child Deserves a Family Act, prohibits child welfare agencies receiving federal funds from discriminating against children, youth, or prospective foster/adoptive parents based on religion, sex (including sexual orientation and gender identity), or marital status. It directly affects LGBTQ youth in foster care - overrepresented at 30% of the system - who face higher risks of trauma, group home placements, and suicide attempts compared to non-LGBTQ peers. Key provisions require agencies to collect data on sexual orientation and gender identity, establish a National Resource Center for LGBTQ youth support, provide cultural competency training, and eliminate discriminatory practices. The law aims to improve safety, permanency, and placement stability by expanding access to family-based care and ensuring equitable services for all children in the system.

Maddy summaryHRES 891 is a ceremonial House resolution supporting the designation of National Rural Health Day, observed annually on the third Thursday of November (November 20, 2025, this year). It recognizes rural health care providers and the challenges rural communities face in accessing care, citing issues like hospital closures and workforce shortages. The resolution does not create new policies, funding, or requirements; it solely expresses the House's support for the day's goals and commitment to improving rural health accessibility. This is a non-binding acknowledgment, not a legislative action with concrete policy changes.

Maddy summaryThe Biomanufacturing Excellence Act of 2025 establishes a National Biopharmaceutical Manufacturing Center of Excellence under the National Institute of Standards and Technology (NIST). It authorizes $120 million in funding for fiscal year 2026 to competitively award a grant to eligible entities - such as public-private partnerships, universities, or consortia - to create this center. The center will advance biopharmaceutical manufacturing technology, strengthen U.S. supply chains for medicines, and develop workforce training programs, with a focus on products critical to national security, health, and economic security. It requires annual progress reports to Congress and mandates the center to collaborate with manufacturers, research institutions, and educational partners to scale innovative production methods.

Maddy summaryThe Farm to School Act of 2025 updates federal programs to connect schools and early childhood programs with local farms. It expands eligibility to include more institutions (beyond just schools) and requires projects to include activities like planting gardens, buying from nearby farmers, or teaching about food/nutrition. The bill increases annual funding to $10 million and sets a $500,000 cap per grant, while prioritizing projects serving socially disadvantaged communities and incorporating tribal foods and traditional practices. It also mandates a review every three years to identify and address barriers for small farmers, tribal producers, and schools trying to implement these programs.

Maddy summaryHR 5992, the "Stuck On Hold Act," requires the Department of Veterans Affairs (VA) to improve wait times for veterans calling its standard customer service phone lines. Within one year of enactment, the VA must implement an automated system that tells callers their expected wait time and offers a callback if the wait exceeds 10 minutes. The bill also directs the VA Secretary to issue guidance aimed at reducing the average call wait time to 10 minutes or less. This directly affects veterans calling VA service lines (excluding the 38 U.S.C. §1720F(h) hotline and emergency department lines).